UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

 

 

For the month of May 2021

 

Commission File Number 001-15170

 

 

GlaxoSmithKline plc

(Translation of registrant's name into English)

 

 

980 Great West Road, Brentford, Middlesex, TW8 9GS

(Address of principal executive office)

 

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F . . . .X. . . . Form 40-F . . . . . . . .

 

 

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____

 

 

 

 

BLOCK LISTING SIX MONTHLY RETURN

 

 

Date: 18 May 2021

 

Name of applicant:		GlaxoSmithKline plc
Name of scheme:		GlaxoSmithKline plc 2017 Deferred Annual Bonus Plan
Period of return:	From:	1 November 2020	To:	30 April 2021
Balance of unallotted securities under scheme(s) from previous return:		0
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):		300,000
Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):		264,481
Equals:  Balance under scheme(s) not yet issued/allotted at end of period:		35,519

 

 

 

Name of applicant:		GlaxoSmithKline plc
Name of scheme:		GlaxoSmithKline plc Share Save Plan 2012
Period of return:	From:	1 November 2020	To:	30 April 2021
Balance of unallotted securities under scheme(s) from previous return:		1,277,629
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):		360,000
Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):		1,255,163
Equals:  Balance under scheme(s) not yet issued/allotted at end of period:		382,466

 

The following GlaxoSmithKline plc Employee Share Schemes have expired and therefore will no longer be included in GlaxoSmithKline plc's Block Listing Six Monthly Returns:

 

●        GlaxoSmithKline plc 2009 Deferred Annual Bonus Plan

 

●        GlaxoSmithKline 2009 Share Option Plan - Ordinary Shares

 

●        GlaxoSmithKline 2009 Share Option Plan - ADS

 

Name of contact:	Victoria Whyte
Telephone number of contact:	020 8047 5000

 

 

 

 

 

SIGNATURES

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.

	GlaxoSmithKline plc
	(Registrant)
Date: May 18, 2021
	By:/s/ VICTORIA WHYTE --------------------------
	Victoria Whyte
	Authorised Signatory for and on
	behalf of GlaxoSmithKline plc